The Warthin-like variant of papillary thyroid carcinomas: a clinicopathologic analysis report of two cases
Author:
Zhao Xing1, Zhang Yijia2, Hao Pengyu3, Zhao Mingzhen4, Shen Xingbin1
Affiliation:
1. Department of Pathology , Affiliated Hospital of Chengde Medical College , Chengde , China 2. School of Clinical Medicine , Changzhi Medical College , Changzhi , China 3. School of Clinical Medicine , Chengde Medical College , Chengde , China 4. Experimental Center , Affiliated Hospital of Chengde Medical College , Chengde , China
Abstract
Abstract
Obejectives
Papillary thyroid carcinoma (PTC) is the most common type of thyroid carcinoma, comparising various subtypes including classical PTC (accounting for approximately 55–65 % of cases) and several variants. The identified variants include papillary microcarcinoma, encapsulated variant, follicular variant, diffuse sclerosing variant, tall cell variant, columnar cell variant, cribriform-morular variant, and Warthin-like variant (WLV-PTC). WLV-PTC is a rare malignant neoplasm.
Case presentation
The present study introduced two cases of WLV-PTC from Affiliated Hospital of Chengde Medical College in retrospect. The macroscopic characteristics, histological feature, immunophenotyping, gene mutations, local invasion, and distant metastasis of the tumors were observed, and the relevant literature on WLV-PTC was reviewed. The tumor cells exhibited nuclear the characteristics similar to those of classic papillary thyroid carcinoma. Immunohistochemical analysis showed strong positivity for thyroid transcription factor 1, cytokeratin 19, Galectin-3, and CK, weak positivity for thyroglobulin, and the Ki-67 proliferation index ranging from 5 to 10 %. Gene mutation analysis revealed that Case 1 had a BRAF V600E mutation, whereas Case 2 had a wild-type mutation. WLV-PTC has histological features similar to those of Warthin tumor originating from salivary gland.
Conclusions
The prognosis of WLV-PTC is similar to that of conventional PTC of comparable size and stage.
Funder
Chengde Science and Technology Research and Development Project
Publisher
Walter de Gruyter GmbH
Reference19 articles.
1. Apel, RL, Asa, SL, LiVolsi, VA. Papillary Hürthle cell carcinoma with lymphocytic stroma. “Warthin-like tumor” of the thyroid. Am J Surg Pathol 1995;19:810–4. https://doi.org/10.1097/00000478-199507000-00009. 2. Kim, M, Cho, SW, Park, YJ, Ahn, HY, Kim, HS, Suh, YJ, et al.. Clinicopathological characteristics and recurrence-free survival of rare variants of papillary thyroid carcinomas in Korea: a retrospective study. Endocrinol Metab (Seoul). 2021;36:619–27. https://doi.org/10.3803/enm.2021.974. 3. Han, F, Zhang, L, Zhang, S, Zhou, H, Yi, X. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K. Int J Clin Exp Pathol 2015;8:5896–901. 4. Bai, Y, Kakudo, K, Jung, CK. Updates in the pathologic classification of thyroid neoplasms: a review of the World Health Organization classification. Endocrinol Metab (Seoul) 2020;35:696–715. https://doi.org/10.3803/enm.2020.807. 5. Maffini, F, Lorenzini, D, Lepanto, D, De Fiori, E, Fumagalli, C, Rappa, A, et al.. A case of Warthin-like papillary thyroid carcinoma with diffuse sclerosing stroma and a novel RET mutation: a new entity or a combined tumour? Ecancermedicalscience 2019;13:965. https://doi.org/10.3332/ecancer.2019.965.
|
|